Logo image of LSDI

LUCY SCIENTIFIC DISCOVERY IN (LSDI) Stock Price, Quote, News and Overview

NASDAQ:LSDI - Nasdaq - CA54960E2033 - Common Stock - Currency: USD

0.5139  -0.16 (-23.29%)

After market: 0.4552 -0.06 (-11.42%)

LSDI Quote, Performance and Key Statistics

LUCY SCIENTIFIC DISCOVERY IN

NASDAQ:LSDI (6/28/2024, 8:12:35 PM)

After market: 0.4552 -0.06 (-11.42%)

0.5139

-0.16 (-23.29%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High12.8
52 Week Low0.44
Market Cap904.46K
Shares1.76M
Float1.23M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO02-09 2023-02-09


LSDI short term performance overview.The bars show the price performance of LSDI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

LSDI long term performance overview.The bars show the price performance of LSDI in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of LSDI is 0.5139 USD. In the past month the price decreased by -40.24%. In the past year, price decreased by -95.53%.

LUCY SCIENTIFIC DISCOVERY IN / LSDI Daily stock chart

LSDI Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 66.89 824.33B
JNJ JOHNSON & JOHNSON 15.42 373.41B
NVO NOVO-NORDISK A/S-SPONS ADR 18.03 276.20B
NVS NOVARTIS AG-SPONSORED ADR 14.17 222.20B
AZN ASTRAZENECA PLC-SPONS ADR 16.81 216.28B
MRK MERCK & CO. INC. 10.7 209.79B
PFE PFIZER INC 7.38 130.19B
SNY SANOFI-ADR 13.74 129.48B
BMY BRISTOL-MYERS SQUIBB CO 6.54 97.65B
GSK GSK PLC-SPON ADR 8.74 77.03B
ZTS ZOETIS INC 25.77 68.05B
TAK TAKEDA PHARMACEUTIC-SP ADR 32.97 47.73B

About LSDI

Company Profile

LSDI logo image Lucy Scientific Discovery, Inc. operates as a psychotropics contract manufacturing company. The company is headquartered in Victoria, British Columbia. The company went IPO on 2023-02-09. The firm is engaged in researching, developing, and manufacturing psychotropic drugs. The firm is a manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies. The company is focused on developing therapies for patients in need, and through its lead candidate SANA-013, dedicated to advancing the understanding and applications of psychedelic medicine, improving mental health outcomes, and enhancing well-being for individuals worldwide. The firm is engaged in the production of a variety of natural, synthetic, and biosynthetic products to meet the needs of the psychotropics-based medicines market. Its products are in the form of raw materials, crude extracts, targeted formulations, single molecule fractions, and white- and private-label products.

Company Info

LUCY SCIENTIFIC DISCOVERY IN

301-1321 Blanshard Street

Victoria BRITISH COLUMBIA CA

Employees: 0

Company Website: https://www.lucyscientific.com/

Phone: 17784105195

LUCY SCIENTIFIC DISCOVERY IN / LSDI FAQ

What is the stock price of LUCY SCIENTIFIC DISCOVERY IN today?

The current stock price of LSDI is 0.5139 USD. The price decreased by -23.29% in the last trading session.


What is the ticker symbol for LUCY SCIENTIFIC DISCOVERY IN stock?

The exchange symbol of LUCY SCIENTIFIC DISCOVERY IN is LSDI and it is listed on the Nasdaq exchange.


On which exchange is LSDI stock listed?

LSDI stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for LUCY SCIENTIFIC DISCOVERY IN stock?

7 analysts have analysed LSDI and the average price target is 35.7 USD. This implies a price increase of 6846.88% is expected in the next year compared to the current price of 0.5139. Check the LUCY SCIENTIFIC DISCOVERY IN stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is LUCY SCIENTIFIC DISCOVERY IN worth?

LUCY SCIENTIFIC DISCOVERY IN (LSDI) has a market capitalization of 904.46K USD. This makes LSDI a Nano Cap stock.


How many employees does LUCY SCIENTIFIC DISCOVERY IN have?

LUCY SCIENTIFIC DISCOVERY IN (LSDI) currently has 0 employees.


What are the support and resistance levels for LUCY SCIENTIFIC DISCOVERY IN (LSDI) stock?

LUCY SCIENTIFIC DISCOVERY IN (LSDI) has a resistance level at 0.65. Check the full technical report for a detailed analysis of LSDI support and resistance levels.


Should I buy LUCY SCIENTIFIC DISCOVERY IN (LSDI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does LUCY SCIENTIFIC DISCOVERY IN (LSDI) stock pay dividends?

LSDI does not pay a dividend.


What is the Price/Earnings (PE) ratio of LUCY SCIENTIFIC DISCOVERY IN (LSDI)?

LUCY SCIENTIFIC DISCOVERY IN (LSDI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-7.2).


LSDI Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

LSDI Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to LSDI. LSDI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LSDI Financial Highlights

Over the last trailing twelve months LSDI reported a non-GAAP Earnings per Share(EPS) of -7.2. The EPS decreased by -96.67% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -263.59%
ROE -13916.75%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-66.29%
Sales Q2Q%N/A
EPS 1Y (TTM)-96.67%
Revenue 1Y (TTM)N/A

LSDI Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to LSDI. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners7.28%
Ins Owners65.53%
Short Float %N/A
Short RatioN/A
Analysts
Analysts82.86
Price Target35.7 (6846.88%)
EPS Next Y78.1%
Revenue Next YearN/A